AU9028098A - Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception - Google Patents

Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception

Info

Publication number
AU9028098A
AU9028098A AU90280/98A AU9028098A AU9028098A AU 9028098 A AU9028098 A AU 9028098A AU 90280/98 A AU90280/98 A AU 90280/98A AU 9028098 A AU9028098 A AU 9028098A AU 9028098 A AU9028098 A AU 9028098A
Authority
AU
Australia
Prior art keywords
progestins
endometrial
oral contraception
atrophizing
sparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU90280/98A
Other languages
English (en)
Inventor
Michael Kafrissen
Haya Taitel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of AU9028098A publication Critical patent/AU9028098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AU90280/98A 1997-08-27 1998-08-20 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception Abandoned AU9028098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5710997P 1997-08-27 1997-08-27
US60057109 1997-08-27
PCT/US1998/017288 WO1999009993A1 (en) 1997-08-27 1998-08-20 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception

Publications (1)

Publication Number Publication Date
AU9028098A true AU9028098A (en) 1999-03-16

Family

ID=22008560

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90280/98A Abandoned AU9028098A (en) 1997-08-27 1998-08-20 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception

Country Status (9)

Country Link
EP (1) EP1007052B1 (cg-RX-API-DMAC7.html)
JP (1) JP2001513566A (cg-RX-API-DMAC7.html)
AT (1) ATE279198T1 (cg-RX-API-DMAC7.html)
AU (1) AU9028098A (cg-RX-API-DMAC7.html)
DE (1) DE69827017T2 (cg-RX-API-DMAC7.html)
DK (1) DK1007052T3 (cg-RX-API-DMAC7.html)
ES (1) ES2230711T3 (cg-RX-API-DMAC7.html)
PT (1) PT1007052E (cg-RX-API-DMAC7.html)
WO (1) WO1999009993A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US7772219B2 (en) * 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
AU2004277998A1 (en) * 2003-10-01 2005-04-14 Janssen Pharmaceutica N.V. Extended triphasic contraceptive regimens
EP1535618A1 (en) 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
FI101601B (fi) * 1987-09-24 1998-07-31 Jencap Res Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmist een valmistusmenetelmässä
DE4104385C1 (cg-RX-API-DMAC7.html) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
DE69827017T2 (de) 2006-03-09
DE69827017D1 (de) 2004-11-18
EP1007052B1 (en) 2004-10-13
WO1999009993A1 (en) 1999-03-04
PT1007052E (pt) 2005-01-31
ES2230711T3 (es) 2005-05-01
DK1007052T3 (da) 2005-01-31
EP1007052A1 (en) 2000-06-14
ATE279198T1 (de) 2004-10-15
JP2001513566A (ja) 2001-09-04

Similar Documents

Publication Publication Date Title
MX9700534A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para tratar las enfermedades de prostata, endometriosis y obesidad.
CA2001618A1 (en) Gestodene-containing agent for transdermal administration
WO1999015210A3 (en) Bioadhesive compositions and methods for topical administration of active agents
AU9041991A (en) Transdermal contraceptive formulations, methods and devices
EP0841936A4 (en) CONJUGATION-STABILIZED THERAPEUTIC AGENT COMPOSITIONS, ADDITIONAL FORMULATIONS AND DIAGNOSTICS
ATE241361T1 (de) Mittel zur hormonalen kontrazeption
WO1995017156A3 (en) Ethanol substitutes
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
MY106242A (en) Pharmaceutical composition for the prevention of sexually transmitted diseases.
PL312219A1 (en) Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
ZA945546B (en) Antifugal nail solution
CA2131911A1 (en) Minimizing progestin associated breakthrough bleeding
TR199801511T2 (xx) Farmas�tik bile�im.
NO20004419D0 (no) Ny anvendelse
WO1994008613A3 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
AU6042201A (en) Cancer therapy
GR3031354T3 (en) Soluble interferon -receptor, its preparation and use.
HUP0203721A2 (hu) Új hormonkészítmény és alkalmazása
AU6153400A (en) Use of agonists of gabab receptors and pharmaceutically acceptable derivates thereof, in the therapy of maintaining nicotine abstinence-dependent patients
PT1007052E (pt) Combinacoes de progestinas de crescimento do endometrico e progestinas de atropia do endometrio com estrogenios, em contracepcao oral
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
NZ504351A (en) Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen
ES2131482A1 (es) Formulacion acuosa de bambuterol.
IT1291895B1 (it) Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase